This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Reasons to Retain Baxter International (BAX) in Your Portfolio Now
by Zacks Equity Research
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
BAXPositive Net Change DVANegative Net Change ALGNPositive Net Change EHCPositive Net Change
medical medical-devices
3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List
by Shaun Pruitt
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.
HAENegative Net Change LNTHPositive Net Change OPCHPositive Net Change
earnings investing medical medical-devices
Intuitive Surgical (ISRG) Stock Gains 20% YTD: Here's Why
by Zacks Equity Research
Intuitive Surgical (ISRG) shares gain on the back of growth in the da Vinci treatment volume and raised procedure prices.
BSXPositive Net Change ECLPositive Net Change ISRGNegative Net Change ALGNPositive Net Change
medical medical-devices
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
by Urmimala Biswas
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
HIMSNegative Net Change HCATPositive Net Change ENOVPositive Net Change
artificial-intelligence medical medical-devices
Exact Sciences (EXAS) to Showcase Favorable Research Outcome
by Zacks Equity Research
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
RMDNegative Net Change EXASPositive Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices
Should You Buy Helios Technologies (HLIO) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HLIOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
by Zacks Equity Research
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.
DVANegative Net Change ALGNPositive Net Change CAHPositive Net Change EHCPositive Net Change
medical medical-devices
What's in Store for Cooper Companies (COO) in Q2 Earnings?
by Zacks Equity Research
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
UHSPositive Net Change THCPositive Net Change COOPositive Net Change BWAYNegative Net Change
medical medical-devices
Here's Why Investors Should Retain ICON (ICLR) Stock Now
by Zacks Equity Research
Investors remain optimistic about ICON (ICLR) due to its impressive strategic pacts and stable solvency.
RMDNegative Net Change ICLRPositive Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Zacks.com featured highlights include Veracyte, Signet Jewelers, UMB Financial and NVIDIA
by Zacks Equity Research
Veracyte, Signet Jewelers, UMB Financial and NVIDIA are part of the Zacks Screen of the Week article.
NVDANegative Net Change SIGPositive Net Change UMBFPositive Net Change VCYTNegative Net Change
consumer-discretionary finance medical-devices semiconductor
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
by Zacks Equity Research
Investors are optimistic about ResMed (RMD) led by strong growth in the U.S. mask and accessories business and its cloud-connected platforms.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change RMDNegative Net Change
medical medical-devices
Inari Medical (NARI) Sues Truvic on Patent Infringement
by Zacks Equity Research
Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change NARINegative Net Change
medical medical-devices
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
by Zacks Equity Research
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
BSXPositive Net Change ECLPositive Net Change DVANegative Net Change CORPositive Net Change
medical medical-devices
Here's Why You Should Buy Boston Scientific (BSX) Stock Now
by Zacks Equity Research
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.
BSXPositive Net Change RMDNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Integer Holdings (ITGR) Gains 23.6% YTD: What's Driving the Stock?
by Zacks Equity Research
Integer Holdings (ITGR) shares soar on the back of growth in the Medical segment. However, fluctuations in raw material prices and the oil and energy market are concerning.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change ITGRNegative Net Change
medical medical-devices
Stereotaxis' (STXS) RMN System to Aid in Treating Arrhythmias
by Zacks Equity Research
Stereotaxis (STXS) announces the completion of treatment of first heart rhythm patients with its Genesis Robotic Magnetic Navigation system in Southern Italy.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change STXSNegative Net Change
medical medical-devices
Here's Why You Should Hold on to IQVIA (IQV) Stock for Now
by Zacks Equity Research
IQVIA (IQV) benefits from a powerful healthcare-specific global IT infrastructure and a robust real-world solutions ecosystem. However, high operating expenses are a headwind.
APTVPositive Net Change IQVNegative Net Change DOCUPositive Net Change
medical medical-devices
Here's Why You Should Retain Edward Lifesciences (EW) for Now
by Zacks Equity Research
Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.
EWNegative Net Change RMDNegative Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices
Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial
by Zacks Equity Research
Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.
MDTPositive Net Change RMDNegative Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Should You Buy New York Times Co. (NYT) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
NYTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Include Alcon (ALC) in Your Portfolio Right Now
by Zacks Equity Research
New product launches and strong solvency bode well for Alcon (ALC).
RMDNegative Net Change ALCPositive Net Change MEDPPositive Net Change HIMSNegative Net Change
medical medical-devices
Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now
by Zacks Equity Research
Ecolab's (ECL) focus on research and development raises optimism about the stock.
BSXPositive Net Change ECLPositive Net Change DVANegative Net Change ALGNPositive Net Change
medical medical-devices
Philips (PHG) Strengthens Patient Monitoring Services in Spain
by Zacks Equity Research
Philips (PHG) announces the wide availability of its ambulatory cardiac monitoring service in Spain, boosting its patient monitoring solutions portfolio.
PHGNegative Net Change DVANegative Net Change ALCPositive Net Change EHCPositive Net Change
medical medical-devices
Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.
MDTPositive Net Change RMDNegative Net Change MEDPPositive Net Change EHCPositive Net Change
earnings medical medical-devices
Here's Why You Should Retain Walgreens Boots (WBA) For Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA), led by strategic alliances and new product launches.
RMDNegative Net Change WBAPositive Net Change MEDPPositive Net Change EHCPositive Net Change
medical medical-devices